• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基线蛋白尿的严重程度可预测自体干细胞移植后免疫球蛋白轻链相关淀粉样变性的肾脏反应。

Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.

作者信息

Leung Nelson, Dispenzieri Angela, Lacy Martha Q, Kumar Shaji K, Hayman Suzanne R, Fervenza Fernando C, Cha Stephen S, Gertz Morie A

机构信息

Division of Nephrology and Hypertension, Mayo Clinic Rochester, Rochester, Minnesota, USA.

出版信息

Clin J Am Soc Nephrol. 2007 May;2(3):440-4. doi: 10.2215/CJN.02450706. Epub 2007 Apr 4.

DOI:10.2215/CJN.02450706
PMID:17699449
Abstract

Ig light chain-associated amyloidosis is a fatal plasma cell proliferative disorder that is characterized by fibril deposition in various organs. High-dose melphalan followed by autologous stem cell transplantation has been shown to improve organ dysfunction and survival. This study was undertaken to investigate factors that influence renal response. Patients who had AL amyloidosis with > or =1 g/d proteinuria and a minimum follow-up of 12 mo were recruited. Renal response was defined by >50% reduction in proteinuria with <25% decline in renal function. Hematologic response was defined as a 50% reduction in serum monoclonal protein or free light chains. Baseline characteristics were examined for relationship to renal response. Thirteen of the 135 patients were excluded for various reasons. Median follow-up was 45.4 mo. Hematologic and renal response was noted in 73 and 43.4% of the patients, respectively. Median response time for the kidney was 10 mo (1 to 40 mo). In univariate analysis, low cardiac troponin T (cTnT), higher albumin, lower proteinuria, and hematologic response were associated with renal response. In multivariate analysis, cTnT and proteinuria were predictive of renal response. Renal response was associated with a longer survival than hematologic response alone. This study showed that severe proteinuria and high cTnT negatively affected renal response after autologous stem cell transplantation. Achievement of renal response was associated with improved survival. These results suggest that early intervention with aggressive therapy is not only justified but recommended to achieve optimal response.

摘要

免疫球蛋白轻链相关淀粉样变性是一种致命的浆细胞增殖性疾病,其特征是在各个器官中出现纤维蛋白沉积。大剂量美法仑随后进行自体干细胞移植已被证明可改善器官功能障碍并提高生存率。本研究旨在调查影响肾脏反应的因素。招募了患有AL淀粉样变性且蛋白尿≥1g/d且至少随访12个月的患者。肾脏反应定义为蛋白尿减少>50%且肾功能下降<25%。血液学反应定义为血清单克隆蛋白或游离轻链减少50%。检查基线特征与肾脏反应的关系。135例患者中有13例因各种原因被排除。中位随访时间为45.4个月。分别有73%和43.4%的患者出现血液学和肾脏反应。肾脏的中位反应时间为10个月(1至40个月)。在单变量分析中,低心肌肌钙蛋白T(cTnT)、较高的白蛋白、较低的蛋白尿和血液学反应与肾脏反应相关。在多变量分析中,cTnT和蛋白尿可预测肾脏反应。与单纯血液学反应相比,肾脏反应与更长的生存期相关。本研究表明,严重蛋白尿和高cTnT对自体干细胞移植后的肾脏反应有负面影响。实现肾脏反应与生存率提高相关。这些结果表明,积极治疗的早期干预不仅合理,而且建议采用以实现最佳反应。

相似文献

1
Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.基线蛋白尿的严重程度可预测自体干细胞移植后免疫球蛋白轻链相关淀粉样变性的肾脏反应。
Clin J Am Soc Nephrol. 2007 May;2(3):440-4. doi: 10.2215/CJN.02450706. Epub 2007 Apr 4.
2
Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis.大剂量美法仑和干细胞移植后的肾脏反应是原发性系统性淀粉样变性患者的一个良好标志物。
Am J Kidney Dis. 2005 Aug;46(2):270-7. doi: 10.1053/j.ajkd.2005.05.010.
3
Long-term outcome of autologous stem cell transplantation in light chain deposition disease.轻链沉积病自体干细胞移植的长期预后
Nephrol Dial Transplant. 2008 Jun;23(6):2052-7. doi: 10.1093/ndt/gfm918. Epub 2008 Jan 4.
4
Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney.肾脏血管受限沉积的免疫球蛋白轻链淀粉样变(AL)患者的临床特征。
Nephrol Dial Transplant. 2012 Mar;27(3):1097-101. doi: 10.1093/ndt/gfr381. Epub 2011 Nov 7.
5
Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.系统性淀粉样变性中的肾脏受累:一项关于生存和肾脏结局的意大利协作研究。
Nephrol Dial Transplant. 2008 Mar;23(3):941-51. doi: 10.1093/ndt/gfm684. Epub 2007 Oct 19.
6
Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.进展性淀粉样变性的自体干细胞移植与严重的移植相关毒性有关。
Wien Klin Wochenschr. 2006 Feb;118(1-2):49-53. doi: 10.1007/s00508-005-0505-x.
7
Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis.针对原发性(AL)淀粉样变性自体外周血干细胞移植中马法兰预处理的风险适应性方法的长期结果
Haematologica. 2006 Dec;91(12):1635-43.
8
Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis.大剂量静脉注射美法仑和自体干细胞移植治疗 AL(原发性)淀粉样变性后的血清游离轻链反应
Bone Marrow Transplant. 2005 Oct;36(7):597-600. doi: 10.1038/sj.bmt.1705106.
9
Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation.在肾移植或不进行干细胞移植的情况下,轻链淀粉样变性(AL)患者的长期预后。
Nephrol Dial Transplant. 2011 Jun;26(6):2032-6. doi: 10.1093/ndt/gfr067. Epub 2011 May 4.
10
Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.采用辅助地塞米松±沙利度胺的风险适应性自体干细胞移植治疗系统性轻链淀粉样变性:一项II期试验的结果
Br J Haematol. 2007 Oct;139(2):224-33. doi: 10.1111/j.1365-2141.2007.06783.x.

引用本文的文献

1
Renal Response Criteria for Clinical Trials in Amyloid Light Chain Amyloidosis.淀粉样轻链淀粉样变性临床试验的肾脏反应标准。
Kidney Int Rep. 2024 Apr 4;9(7):1986-1994. doi: 10.1016/j.ekir.2024.03.033. eCollection 2024 Jul.
2
Vincristine, Doxorubicin, and Dexamethasone Induction before Autologous Stem Cell Transplantation in Patients with AL Amyloidosis: A Retrospective Comparison with Frontline Stem Cell Transplantation.硼替佐米、多柔比星和地塞米松诱导治疗联合自体干细胞移植治疗 AL 淀粉样变性:与一线干细胞移植的回顾性比较。
Intern Med. 2022 Oct 1;61(19):2853-2860. doi: 10.2169/internalmedicine.9039-21. Epub 2022 Feb 26.
3
Renal ablation using bilateral ureteral ligation for nephrotic syndrome due to renal amyloidosis.
采用双侧输尿管结扎术对肾淀粉样变性所致肾病综合征进行肾脏消融。
Clin Kidney J. 2012 Apr;5(2):153-154. doi: 10.1093/ndtplus/sfr160. Epub 2012 Feb 22.
4
Oligosecretory Myeloma With Amyloidosis and Alopecia.伴有淀粉样变性和脱发的寡分泌性骨髓瘤
J Investig Med High Impact Case Rep. 2018 Jan 24;6:2324709617752737. doi: 10.1177/2324709617752737. eCollection 2018 Jan-Dec.
5
Estimation of Daily Proteinuria in Patients with Amyloidosis by Using the Protein-To-Creatinine ratio in Random Urine Samples.通过随机尿样中的蛋白质与肌酐比值估算淀粉样变性患者的每日蛋白尿
Rare Tumors. 2015 Feb 18;7(1):5686. doi: 10.4081/rt.2015.5686. eCollection 2015 Feb 11.
6
Amyloid nephropathy.淀粉样肾病
Clin Kidney J. 2014 Apr;7(2):97-106. doi: 10.1093/ckj/sfu021. Epub 2014 Mar 13.
7
Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma.尽管新诊断的多发性骨髓瘤接受全程治疗后肾功能有所改善,但肾功能不全仍具有不良预后意义。
Leukemia. 2015 May;29(5):1195-201. doi: 10.1038/leu.2015.15. Epub 2012 Feb 2.
8
Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting.严格的患者选择可改善初治及复发情况下自体干细胞移植后系统性轻链淀粉样变性的治疗效果。
Haematologica. 2014 Dec;99(12):e260-3. doi: 10.3324/haematol.2014.108191. Epub 2014 Sep 5.
9
Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases.Cast 肾病和其他单克隆免疫球蛋白相关肾脏疾病患者的尿白蛋白排泄模式。
Clin J Am Soc Nephrol. 2012 Dec;7(12):1964-8. doi: 10.2215/CJN.11161111. Epub 2012 Sep 27.
10
Treatment of immunoglobulin light chain amyloidosis.免疫球蛋白轻链淀粉样变性的治疗。
Curr Hematol Malig Rep. 2009 Apr;4(2):91-8. doi: 10.1007/s11899-009-0013-6.